Materials-and-methods sections often begin with a simple supplier line, but reviewers and laboratory materials managers increasingly expect traceability from catalogue item to batch documentation. For research-use-only materials, that means matching the exact vial in hand to the certificate that supports the draft. A practical way to do this is to ask the supplier for a CoA by quoting the vial reference, rather than relying on a product name alone. This approach helps keep the manuscript record factual, auditable and aligned with controlled in-vitro research workflows.
Why the Vial Reference Belongs in Your Documentation Request
A generic entry such as “research peptide, supplier catalogue” may identify the product family, but it does not distinguish one vial from another. Vial labels are the bridge between the physical material and the document trail. Research Sciences describes vial labels as combining the SKU code and expiry date, for example BPC10-03/27, with the reference linking to the corresponding CoA. When contacting the supplier about documentation, quoting that exact reference gives the team a precise starting point for locating the relevant batch record.
This matters because researchers should not import a headline purity statement into a manuscript without checking the batch document. Research Sciences currently publishes a ≥99% verified purity line, and its FAQs describe peptides as typically supplied at ≥99% purity with HPLC testing, but the exact purity is stated on the CoA. Treat public claims as published wording to reconfirm, not as a substitute for the certificate attached to the specific vial. Before relying on any public claim in a draft, check the live Peptide uk pages for current wording, then reconcile it with the actual batch CoA. Where the homepage lists “CoAs Janoshik Analytical Reports”, that should be checked against the specific CoA supplied for the batch rather than assumed from the product listing.
There is also a subtlety around restocks. The FAQs state that restocked products may carry the same Internal Test Reference, or ITR, as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. For a materials-and-methods draft, those details should be kept out of the scientific claim and treated only as stock-control notes. The exact vial reference, not a visual feature, is the reliable identifier to quote.
How to Write the CoA Request Around Your Materials-and-Methods Draft
The request can be short, but it should be specific enough to avoid a back-and-forth about which vial is meant. A useful subject line follows the pattern “CoA request — [vial reference] — [catalogue item] — manuscript documentation”. In the body, identify the exact vial reference from the label, the product name and SKU where they appear, the order or dispatch reference if available, and the date the material was received. State that the purpose is documentation for a research manuscript’s materials-and-methods section, not clinical or therapeutic use.
Ask the supplier to confirm whether the CoA matches the quoted vial reference. It is reasonable to request the batch CoA showing the documented tests, as described by the supplier for that product, and to ask whether the reference on the certificate corresponds to the label in hand. If the draft includes statements about identity, purity or contaminant screening, keep them tied to the CoA wording rather than general product marketing. Research Sciences describes batch-level analytical verification supporting purity, identity and contaminant screening, with CoAs linked to supported products; the researcher should still open and check the document for the exact batch.
Keep the request within research-use-only terms. All products are strictly for controlled laboratory and analytical research; they are not medicines, medical devices, injectables, treatments or food supplements, and they are not for human or veterinary use. The supplier does not provide therapeutic, medical, performance, injection, ingestion or dosing guidance. A CoA request should therefore focus on analytical documentation, storage and handling within an in-vitro workflow, not on administration, clinical application or suitability for any human or animal use. If the draft uses an older brand name, note factually that Research Sciences is the parent company of Imperial Peptides UK per the FAQ, and that Imperial Peptides UK continues to operate as a brand. Keep the shop name and label reference consistent so the audit trail is clear.
Matching the CoA to the Draft: Wording, Limits and Reviewer-Ready Records
Use certificate wording, not assumed specifications
In the materials-and-methods text, describe the material as research-use-only and identify the supplier, catalogue item and vial reference. Then state the documented analytical information as it appears on the batch CoA. Avoid writing “≥99% purity” as though it were a universal product constant; if the draft mentions purity, identity or contaminant screening, anchor the sentence to the CoA for the quoted vial. Research Sciences describes an expanded testing framework including heavy metals and endotoxin screening alongside CoA documentation, but the presence of those tests should be verified on the actual document before being written into a manuscript. Do not invent certificate numbers, pass/fail limits or testing methods beyond what the supplier has published and the CoA states.
Keep handling language inside the laboratory workflow
Storage and handling sentences should stay procedural. Lyophilised materials are described as requiring storage at −20°C or below, sealed with desiccant and protected from moisture, heat and light, with reconstituted material stored at 2–8°C for short-term laboratory use. Where reconstitution is part of an in-vitro assay, describe diluent volume and target concentration in laboratory terms only. The shop’s reconstitution calculator and materials are for laboratory research use only and must not be used for human or veterinary dosing. Repeat in the draft that materials are not for human or veterinary use, especially if the methods section could otherwise be read as implying clinical or diagnostic application.
Keep a batch-level record beside the draft
For studies using more than one vial, quote each vial reference separately and archive the corresponding CoA with the notebook entry, receipt and draft. If a reference cannot be matched to a CoA, ask the supplier to clarify rather than substituting a certificate from a different batch. The vial reference is also the correct detail to quote when contacting the shop about documentation, because it links the physical container to the supporting record. Archive the request, the supplier reply and the CoA beside the materials-and-methods draft so the documentation trail is complete before submission.
Perth biomedical researcher who motorbiked across Central Asia and never stopped writing. Lachlan covers CRISPR ethics, desert astronomy, and hacks for hands-free videography. He brews kombucha with native wattleseed and tunes didgeridoos he finds at flea markets.